Loading...
China Sunsine Chemical Holdings Ltd.
QES.SI•SES
Basic MaterialsChemicals - Specialty
S$0.56
S$0.00(0.00%)
China Sunsine Chemical Holdings Ltd. (QES.SI) Financial Performance & Statements
Review China Sunsine Chemical Holdings Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.72%
↑ 0.72%
Operating Income Growth
19.90%
↑ 19.90%
Net Income Growth
13.81%
↑ 13.81%
Operating Cash Flow Growth
-3.39%
↓ 3.39%
Operating Margin
12.54%
↑ 12.54%
Gross Margin
24.30%
↑ 24.30%
Net Profit Margin
9.65%
↑ 9.65%
ROE
10.36%
↑ 10.36%
ROIC
13.08%
↑ 13.08%
China Sunsine Chemical Holdings Ltd. (QES.SI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for China Sunsine Chemical Holdings Ltd. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $883.20M | $883.20M | $1.75B | $874.55M |
| Cost of Revenue | $675.00M | $675.00M | $1.32B | $657.75M |
| Gross Profit | $208.20M | $208.20M | $433.80M | $216.80M |
| Gross Profit Ratio | $0.24 | $0.24 | $0.25 | $0.25 |
| R&D Expenses | $8.15M | $8.15M | $69.93M | $34.95M |
| SG&A Expenses | $86.80M | $86.80M | $147.87M | $73.90M |
| Operating Expenses | $94.95M | $94.95M | $217.80M | $108.85M |
| Total Costs & Expenses | $769.95M | $769.95M | $1.53B | $766.60M |
| Interest Income | $0.00 | $0.00 | $35.22M | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $31.10M | $31.10M | $35.35M | $35.35M |
| EBITDA | $144.35M | $144.35M | $143.30M | $143.30M |
| EBITDA Ratio | $0.16 | $0.16 | $0.08 | $0.16 |
| Operating Income | $113.25M | $113.25M | $216.001M | $107.95M |
| Operating Income Ratio | $0.13 | $0.13 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | $45.25M | $45.25M | -$81.95M | $26.10M |
| Income Before Tax | $158.50M | $158.50M | $134.05M | $134.05M |
| Income Before Tax Ratio | $0.18 | $0.18 | $0.08 | $0.15 |
| Income Tax Expense | $40.95M | $40.95M | $39.65M | $39.65M |
| Net Income | $117.55M | $117.55M | $94.40M | $94.40M |
| Net Income Ratio | $0.13 | $0.13 | $0.05 | $0.11 |
| EPS | $0.12 | $0.12 | $0.04 | $0.10 |
| Diluted EPS | $0.12 | $0.12 | $0.04 | $0.10 |
| Weighted Avg Shares Outstanding | $954.20M | $954.20M | $957.85M | $957.85M |
| Weighted Avg Shares Outstanding (Diluted) | $954.20M | $954.20M | $957.85M | $957.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan